Atwater Malick LLC Pfizer Inc Transaction History

Atwater Malick LLC

$284 Million
Q1 2024

A detailed history of Atwater Malick LLC transactions in Pfizer Inc stock. As of the latest transaction made, Atwater Malick LLC holds 149,761 shares of PFE stock, worth $4.19 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares

149,761

Previous 173,939 13.9%

Holding current value

$4.19 Million

Previous $5.01 Million 17.02%

% of portfolio

1.47%

Previous 1.96%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$25.89 - $29.73 $625,968 - $718,811	-24,178 Reduced 13.9%	149,761 $4.16 Million
Q4 2023 Jan 11, 2024	BUY	$26.13 - $33.94 $211,653 - $274,914	8,100 Added 4.88%	173,939 $5.01 Million
Q3 2023 Oct 17, 2023	BUY	$32.09 - $37.51 $63,024 - $73,669	1,964 Added 1.2%	165,839 $5.5 Million
Q2 2023 Jul 17, 2023	BUY	$36.12 - $41.79 $277,509 - $321,072	7,683 Added 4.92%	163,875 $6.01 Million
Q1 2023 Apr 19, 2023	BUY	$39.39 - $51.28 $173,591 - $225,990	4,407 Added 2.9%	156,192 $6.37 Million

Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $178,022 - $232,388	4,264 Added 2.89%	151,785 $7.78 Million
Q3 2022 Nov 02, 2022	BUY	$43.76 - $53.42 $130,361 - $159,138	2,979 Added 2.06%	147,521 $6.46 Million
Q2 2022 Jul 21, 2022	BUY	$46.53 - $55.17 $110,462 - $130,973	2,374 Added 1.67%	144,542 $7.58 Million
Q1 2022 Apr 08, 2022	BUY	$45.75 - $56.69 $216,580 - $268,370	4,734 Added 3.44%	142,168 $7.36 Million
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $129,827 - $192,447	3,142 Added 2.34%	137,434 $8.12 Million
Q3 2021 Oct 14, 2021	BUY	$39.25 - $50.42 $149,150 - $191,596	3,800 Added 2.91%	134,292 $5.78 Million
Q2 2021 Jul 26, 2021	BUY	$35.91 - $40.68 $240,848 - $272,840	6,707 Added 5.42%	130,492 $5.11 Million
Q1 2021 May 21, 2021	SELL	$33.49 - $37.77 $106,665 - $120,297	-3,185 Reduced 2.51%	123,785 $4.49 Million
Q4 2020 Jan 20, 2021	BUY	$33.47 - $42.56 $96,326 - $122,487	2,878 Added 2.32%	126,970 $4.67 Million
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $61,658 - $72,339	1,942 Added 1.59%	124,092 $4.55 Million
Q2 2020 Jul 23, 2020	BUY	$30.12 - $36.54 $125,479 - $152,225	4,166 Added 3.53%	122,150 $3.99 Million
Q1 2020 Apr 24, 2020	BUY	$27.03 - $38.62 $42,491 - $60,710	1,572 Added 1.35%	117,984 $3.85 Million
Q4 2019 Jan 07, 2020	BUY	$32.92 - $37.36 $163,250 - $185,268	4,959 Added 4.45%	116,412 $4.56 Million
Q3 2019 Oct 15, 2019	BUY	$32.49 - $42.13 $233,148 - $302,324	7,176 Added 6.88%	111,453 $4.01 Million
Q2 2019 Jul 11, 2019	BUY	$36.98 - $41.52 $58,835 - $66,058	1,591 Added 1.55%	104,277 $4.52 Million
Q1 2019 Apr 12, 2019	BUY	$37.5 - $41.2 $15,150 - $16,644	404 Added 0.39%	102,686 $4.36 Million
Q4 2018 Mar 21, 2019	BUY	$38.47 - $43.86 $3.93 Million - $4.49 Million	102,282 New	102,282 $4.47 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwater Malick LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atwater Malick LLC with notifications on news.

Account

Atwater Malick LLC Pfizer Inc Transaction History